A Master Protocol (LY900023) for Children and Young Adults With Cancer
Phase 2
105
about 7.4 years
1–39
29 sites in AL, AZ, CA +18
What this study is about
This trial is testing several drugs to treat cancer in children and young adults. The goal of this master protocol is to improve how research sites carry out clinical trials by providing a common research plan. New studies will be added as new drugs are developed against different cancers.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Abemaciclib
- 2.Take Cyclophosphamide
- 3.Take Docetaxel
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
abemaciclib, cyclophosphamide (Alkylating chemotherapy; crosslinks DNA strands), docetaxel, gemcitabine, irinotecan, ramucirumab, temozolomide, vinorelbine
oral (Oral Tablet), infusion, injection (Injection), injection, intravenous